// App-Quantinova.ai

90 : Inhibition of HMGB1 attenuates the inflammatory response in keratinocytes

Researchers

Presenter

  • K.G. Bui

Principal Investigators

  • A. Keith

  • C. Ebens

  • A. Bielinsky

  • J. Tolar

Medical Centers

  • Department of Genetics, Cell Biology, and Development, University of Minnesota Twin Cities, Minneapolis, Minnesota, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Dermatology

  • Genetic Disorder

Disease

  • Squamous cell carcinoma

  • Epidermolysis bullosa

  • Solid malignancies

  • Epidermolysis bullosa dystrophica, autosomal recessive

Biomarkers

  • High Mobility Group Box 1

  • Interleukin 6

  • Serpin B3

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved